NCT06342700View on ClinicalTrials.gov

A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

April 23, 2024

Study Completion Date

April 23, 2024

Conditions
Autoimmune DisorderHealthy Volunteers
Interventions
DRUG

Rilzabrutinib crystalline form

Pharmaceutical form:Film coated tablet Route of administration:Oral

DRUG

Rilzabrutinib amorphous form

Pharmaceutical form:Film coated tablet Route of administration:Oral

Trial Locations (1)

55114

Nucleus Network Site Number : 8400001, Saint Paul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT06342700 - A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants | Biotech Hunter | Biotech Hunter